Cover
Vol. 3 No. 2 (2025)

Published: December 1, 2025

Pages: 12-30

Original Article

Frequency and Awareness of Lifestyle Medication Use among University Students in Kut City, Iraq

Abstract

Background: Lifestyle medicines (LSMs) are used to help people alter their lifestyles. These medicines are used for purposes other than medicine or health. Aims & Objectives: The objective of the study was to evaluate the prevalence of LSM use among the students of the university, the rationale for their utilization, and the kinds of consequences, in order to give useful data for reasoning and prevention of this problem. Method: A cross-sectional descriptive research study was carried out. university students in Wasit, Iraq, by using a self-administered questionnaire. Participants were usefully recruited through online platforms. The questionnaire consist of four sections, including sociodemographic profile, knowledge, and awareness in a validated questionnaire format. Results: A total of 500 students aged between 18-25 and more were surveyed. The number who utilize LSMs was 470(94%). The most common agents utilized by a high number of students were vitamins 136(28.94%) followed by Non-steroidal anti-inflammatory drugs 41(8.72%), then caffeine-containing substances 38(8.09% ). The most frequent adverse effects related to use of LSMs were lethargy and fatigue and 68 (14.47%), and insomnia 41(8.72%). Conclusion: Awareness of Lifestyle Medications (LSMs) was moderate, with medical advice being the primary source of information. The study found a high prevalence of LSM use, with vitamins being the most commonly used. Adverse effects varied among users, with fatigue and the lethargy being the most reported. Despite diverse perceptions toward LSMs, a significant differences in awareness were noted based on gender and study field, highlighting the need for targeted education and intervention strategies.

References

  1. Rahman SZ, Gupta V, Sukhlecha A, Khunte Y. Lifestyle drugs: concept and impact on society. Indian Journal of Pharmaceutical Sciences. 2010 Jul;72(4):409.
  2. Møldrup C. The use of the terms ‘lifestyle medicines’ or ‘lifestyle drugs’. Pharmacy World and Science. 2004 Aug;26:193-6.
  3. Mwambete KD, Shemsika T. Prevalence of life style drugs usage and perceived effects among university students in Dar es Salaam. Am J Biomed Res. 2014 May 20;2(2):29-35.
  4. Harth W, Seikowski K, Hermes B. Lifestyle Drugs in Old Age–A Mini-Review. Gerontology. 2009 Nov 12;55(1):13-20.
  5. Jernigan D, Noel J, Landon J, Thornton N, Lobstein T. Alcohol marketing and youth alcohol consumption: a systematic review of longitudinal studies 2008. Addiction. 2017 Jan;112:7-20.
  6. Moynihan R, CG P, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering-Commentary: Medicalisation of risk factors. BMJ. 2002 Apr 13;324(7342):886-91.
  7. Oliveira LG, Alberghini DG, Santos BD, Andrade AG. Polydrug use among college students in Brazil: a nationwide survey. Brazilian Journal of Psychiatry. 2013 Jul;35:221-30.
  8. d'Angelo LS, Savulich G, Sahakian BJ. Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure. British Journal of Pharmacology. 2017 Oct;174(19):3257-67.
  9. Marouf BH, Saeed AG, Othman Z, Karim S, Gharib S, Ahmed R. Awareness and Frequency of using Lifestyle Medications among University Students in Kurdistan Region-Iraq. Iraqi Journal of Pharmaceutical Sciences. 2023 Jun 20;32(1):185-93.
  10. Schelle KJ, Olthof BM, Reintjes W, Bundt C, Gusman-Vermeer J, Van Mil AC. A survey of substance use for cognitive enhancement by university students in the Netherlands. Frontiers in Systems Neuroscience. 2015 Feb 17;9:10.
  11. Mounika I, Ramu B. Lifestyle drugs: concept and impact on society. Journal of Human Virology & Retrovirology. 2018;6:46-9.
  12. Flower RJ. Lifestyle and non-medical uses of drugs. Rang and Dale’s Pharmacology. 6th ed. London: Churchill Livingstone. 2007:765-9.
  13. Outram SM. The use of methylphenidate among students: the future of enhancement?. Journal of Medical Ethics. 2010 Apr 1;36(4):198-202.
  14. Powell R, Kahane G, Savulescu J. Evolution, genetic engineering, and human enhancement. Philosophy & Technology. 2012 Dec;25:439-58.
  15. Kobayashi E, Sato Y, Umegaki K, Chiba T. The prevalence of dietary supplement use among college students: A nationwide survey in Japan. Nutrients. 2017 Nov 15;9(11):1250.
  16. Trilk J, Nelson L, Briggs A, Muscato D. Including lifestyle medicine in medical education: rationale for American College of Preventive Medicine/American Medical Association resolution 959. American Journal of Preventive Medicine. 2019 May 1;56(5):e169-75.
  17. Mazanov J, Dunn M, Connor J, Fielding ML. Substance use to enhance academic performance among Australian university students. Performance Enhancement & Health. 2013 Sep 1;2(3):110-8.
  18. Conner M, Kirk SF, Cade JE, Barrett JH. Why do women use dietary supplements? The use of the theory of planned behaviour to explore beliefs about their use. Soc Sci Med. 2001;52:621-33.
  19. Frank E, Bendich A, Denniston M. Use of vitamin-mineral supplements by female physicians in the United States. Am J Clin Nutr. 2000 Oct;72:969–75.
  20. Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: clinical applications. JAMA. 2002;287:3127–9.
  21. Asplund K. Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review. J Intern Med. 2002;251:372–92.
  22. Briançon S, Boini S, Bertrais S, Guillemin F, Galan P, Hercberg S. Long-term antioxidant supplementation has no effect on health-related quality of life. Int J Epidemiol. 2011 Dec 1;40(6):1605-16.
  23. Park SY, Murphy SP, Martin CL, Kolonel LN. Nutrient intake from multivitamin/mineral supplements is similar among users from five ethnic groups: the Multiethnic Cohort Study. J Am Diet Assoc. 2008 Mar 1;108(3):529-33.
  24. Garcia-Alvarez A, Egan B, De Klein S, Dima L, Maggi FM, Isoniemi M, Ribas-Barba L, Raats MM, Meissner EM, Badea M, Bruno F. Usage of plant food supplements across six European countries: findings from the PlantLIBRA consumer survey. PloS One. 2014 Mar 18;9(3):e92265.
  25. Wiltgren AR, Booth AO, Kaur G, Cicerale S, Lacy KE, Thorpe MG, Keast RS, Riddell LJ. Micronutrient supplement use and diet quality in university students. Nutrients. 2015 Feb 5;7(2):1094-107.
  26. García-Cortés M, Robles-Díaz M, Ortega-Alonso A, Medina-Caliz I, Andrade RJ. Hepatotoxicity by dietary supplements: a tabular listing and clinical characteristics. Int J Mol Sci. 2016 Apr 9;17(4):537.
  27. Grubbs V, Plantinga LC, Tuot DS, Hedgeman E, Saran R, Saydah S, Rolka D, Powe NR. Americans' use of dietary supplements that are potentially harmful in CKD. Am J Kidney Dis. 2013 May 1;61(5):739-47.
  28. Arnold JD, Iber FL, Burt RA, Gruber Jr CM. Comparison of fenoprofen calcium, ibuprofen and placebo in primary dysmenorrhea. J Med. 1983 Jan 1;14(5-6):337-50.
  29. El-Nimr NA, Bassiouny SH, Tayel DI. Pattern of caffeine consumption among university students. J High Inst Public Health. 2019 Dec 1;49(3):154-61.
  30. Ghozayel M, Ghaddar A, Farhat G, Nasreddine L, Kara J, Jomaa L. Energy drinks consumption and perceptions among University Students in Beirut, Lebanon: A mixed methods approach. PloS One. 2020 Apr 30;15(4):e0232199.
  31. Mahoney CR, Giles GE, Marriott BP, Judelson DA, Glickman EL, Geiselman PJ, Lieberman HR. Intake of caffeine from all sources and reasons for use by college students. Clin Nutr. 2019 Apr 1;38(2):668-75.
  32. Budney AJ, Brown PC, Griffiths RR, Hughes JR, Juliano LM. Caffeine withdrawal and dependence: a convenience survey among addiction professionals. J Caffeine Res. 2013 Jun 1;3(2):67-71.
  33. Christopher G, Sutherland D, Smith A. Effects of caffeine in non‐withdrawn volunteers. Hum Psychopharmacol. 2005 Jan;20(1):47-53.
  34. Ferré S. Mechanisms of the psychostimulant effects of caffeine: implications for substance use disorders. Psychopharmacology. 2016 May;233:1963-79.
  35. Zahra R, Maqsood U, Latif MZ, Athar H, Shaikh GM, Hassan SB. Caffeine consumption & perception of its effects amongst university students. In: Proceedings. 2020;34(4):46-51.
  36. Coveney CM. Awakening expectations: Exploring social and ethical issues surrounding the medical and non-medical uses of cognition enhancing drugs in the UK (Doctoral dissertation, University of Nottingham).
  37. Coveney CM, Nerlich B, Martin P. Modafinil in the media: metaphors, medicalisation and the body. Soc Sci Med. 2009 Feb 1;68(3):487-95.
  38. Stein MD, Kanabar M, Anderson BJ, Lembke A, Bailey GL. Reasons for benzodiazepine use among persons seeking opioid detoxification. J Subst Abuse Treat. 2016 Sep 1;68:57-61.
  39. Egbi OG, Kasia B. Prevalence, determinants and perception of use of skin lightening products among female medical undergraduates in Nigeria. Skin Health Dis. 2021 Sep;1(3):e46.
  40. Henness S, Perry CM. Orlistat: a review of its use in the management of obesity. Drugs. 2006 Aug;66:1625-56.
  41. Ross R, Freeman JA, Janssen I. Exercise alone is an effective strategy for reducing obesity and related comorbidities. Exerc Sport Sci Rev. 2000 Oct 1;28(4):165-70.
  42. Lexchin J. Lifestyle drugs: issues for debate. CMAJ. 2001 May 15;164(10):1449-51.
  43. Abukhalaf AA, Alomar AA, Alsalame NM, Sumaya OY, Alessa OM, Alasbali MM, Alaska YA. Inappropriate use of beta-blockers among medical and dental students at King Saud University, Riyadh. J Fam Med Prim Care. 2020 Aug 1;9(8):4391-5.
  44. Chiba T, Kobayashi E, Okura T, Sekimoto M, Mizuno H, Saito M, Umegaki K. An educational intervention improved knowledge of dietary supplements in college students. BMC Public Health. 2020 Dec;20:1-2.
  45. Chaplin TM, Aldao A. Gender differences in emotion expression in children: a meta-analytic review. Psychol Bull. 2013 Jul;139(4):735.